Appointment booking for Dr. Jonathan Kolitz, MD is currently not available.Dr. Jonathan Kolitz, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Jonathan Kolitz, MD (he/him) is a Oncologist in Lake Success, NY with over 18 years of experience. What is your opinion of Dr. Jonathan Kolitz, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Jonathan Kolitz, MD has received over $53,768 which includes payments from the following companies:
$9,247.70 from Daiichi Sankyo Inc.
$8,899.41 from Novartis Pharmaceuticals Corporation
$7,767.54 from Celgene Corporation
$5,617.42 from AbbVie, Inc.
$5,549.33 from Pharmacyclics LLC, An AbbVie Company
$4,575.63 from Gilead Sciences Inc
$3,549.27 from Pfizer Inc.
$2,717.20 from Incyte Corporation
$2,596.00 from Amgen Inc.
$1,497.36 from Jazz Pharmaceuticals Inc.
$990.91 from Seattle Genetics, Inc.
$716.17 from Alexion Pharmaceuticals, Inc.
$44.78 from Genentech USA, Inc.
Payments received by Dr. Jonathan Kolitz, MD were from the following categories:
$41,608.50 Consulting Fee
$7,428.43 Travel and Lodging
$1,965.00 Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!